ArticleCellular oncology (Dordrecht, Netherlands)2024

A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells.

Zhifeng Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.